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A B S T R A C T
Purpose: In this study, we present the results obtained from a series of patients with refractory temporal
lobe epilepsy (r-TLE) who underwent hippocampal deep brain stimulation (Hip-DBS).
Methods: Nine consecutive adult patients were studied. Low-frequency and high-frequency stimulation
was carried out immediately after the insertion of each electrode. Chronic continuous high-frequency
stimulation was used during treatment. The mean follow-up time was 30.1 months. The mean age of the
patients was 37.2 years. The MRI scan was normal in three patients; four patients had bilateral mesial
temporal sclerosis (MTS), and two had unilateral MTS.
Results: The patients with unilateral MTS received unilateral implantation and experienced a 76% and an
80% reduction in seizure frequency after Hip-DBS. All patients with normal MRI scans were implanted
bilaterally. Two of these patients received unilateral activation of the electrodes and experienced a 97%
and an 80% reduction in seizure frequency; the third patient had bilateral activation of the device and
was a non-responder. All patients with bilateral MTS were implanted bilaterally. Three of these patients
received unilateral activation of the device and experienced a 66%, a 66% and a 100% reduction in seizure
frequency after Hip-DBS; one patient had bilateral electrode activation, and was a non-responder.
Whenever present, generalised tonic–clonic seizures disappeared completely after Hip-DBS.
Conclusions: Although performed on a relatively small number of patients, Hip-DBS was safe and
effective in our patients with r-TLE. Seven of the nine patients were considered responders. Hip-DBS
might represent a useful therapeutic option in patients with refractory temporal lobe epilepsy who were
not candidates for resective surgery or have had previous failed procedures.
 2013 British Epilepsy Association. Published by Elsevier Ltd. All rights reserved.
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Deep brain stimulation (DBS) has been used with an increasing
frequency to treat patients with refractory epilepsy who were not
good candidates for conventional resective surgery. Two large
randomised clinical trials showed that DBS was safe and effective
in the treatment of refractory epilepsy. Fisher et al.1 reported the
effectiveness of intermittent anterior thalamic stimulation, while
Morrell et al.2 studied the outcome after responsive DBS, in a study
that included a signiﬁcant number of patients with temporal lobe
epilepsy.
Hippocampal DBS (Hip-DBS) has been rarely reported in the
literature. The rationale for Hip-DBS was based on the relevant role
played by the hippocampus in both seizure generation and spread,
as frequently seen during invasive neurophysiologic monitoring* Corresponding author at: Clinica de Epilepsia de Sao Paulo, R Dr Alceu de
Campos Rodrigues, 247 # 121, CEP 04544-000, Sao Paulo, SP, Brazil.
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1059-1311/$ – see front matter  2013 British Epilepsy Association. Published by Else
http://dx.doi.org/10.1016/j.seizure.2013.08.005and surgery. Presently, all series included a relatively small
number of patients, used different stimulation paradigms and
recruited heterogeneous patient populations.3–8
We present the results obtained from a series of patients with
refractory temporal lobe epilepsy who underwent Hip-DBS.
2. Methods
Nine consecutive adult patients (seven men) with TLE who
were surgically treated between 2009 and 2011 at the Hospital
Brigadeiro Epilepsy Surgery Program were studied. The pre-
operative work-up consisted of clinical history, neurological
examination, interictal and ictal EEG, and MRI.
Preoperative patient characteristics such as sex, age at seizure
onset, age at presentation, seizure type and frequency, and
antiepileptic drug (AED) regimen were recorded.
The clinical diagnosis was based on the International Classiﬁ-
cation of Seizures (1981) and Epileptic Syndromes (1989). The
following clinical characteristics were considered diagnostic for
TLE: simple partial seizures (SPS) of the de´ja` vu or jamais vu type, or
SPS including epigastric or psychic manifestations (i.e., fear)vier Ltd. All rights reserved.
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and masticatory automatisms, which may be accompanied by
superior limb automatisms or contralateral superior limb dystonia.
All patients had 32-channel interictal and ictal EEG recordings
(10–20 system; at least three seizures recorded) including
zygomatic electrodes. The presence of temporal lobe interictal
spiking and the absence of extra-temporal discharges were
considered ﬁndings related to TLE.
All patients had MRI examinations including sequences that
allowed the adequate study of the hippocampal formation: 1 mm
thick (0.3 mm interval) FLAIR, T2 and IR coronal slices perpendic-
ular to the hippocampal axis; 3 mm thick T1, T2, gradient echo,
FLAIR and IR axial slices and T1 sagittal slices. Images were visually
reviewed by two members of the epilepsy team independently.
Patients underwent Hip-DBS under general anaesthesia and
intra-operative scalp EEG monitoring. Electrodes (Kinetra system,
3387 Electrodes, Medtronic Inc., Minneapolis) were inserted with
the patient in a prone position, through occipital burr holes.
Planning was based on stereotactic CT/MRI fusion; the distal
contact of the electrode was aimed at the anterior hippocampal
head and inserted through the occipital burr hole along the axis of
the hippocampus proper, as determined by the fused CT/MRI
datasets. Intra-operative neuronavigation was used during elec-
trode insertion. Intra-operative low frequency (6 Hz; 4 V; 300 ms)
and high frequency (130 Hz; 4 V; 300 ms) stimulation was carried
out immediately after the insertion of each electrode. The
generator was turned off after this intra-operative neurophysio-
logical study and programmed on an out-patient basis after the
skin stitches were removed. A post-operative volumetric CT scan
documented the exact position of the electrode.
Chronic continuous high frequency stimulation was used
during treatment (1–3.5 V; 130 Hz; 300 ms). Bipolar continuous
stimulation between the contacts of the more distal and the more
proximal electrodes was carried out, aiming to stimulate the entire
implanted area. The voltage was increased in 0.2 V increments in
2-week intervals, to a maximum of 3.5 V, or until the patient was
rendered seizure-free or adverse effects appeared.
The reduction in seizure frequency was studied in each patient
after Hip-DBS. Follow-up time ranged from 15 to 50 months
(mean = 30.1 months). Medications were kept stable during the
study. Patients with at least a 50% reduction in seizure frequency
were considered responders.
In this sample, age ranged from 23 to 53 years (mean = 37.2).
Age of seizure onset ranged from 0.5 to 22 years (mean = 11.7
years).
Interictal EEG showed bilateral temporal lobe spiking in seven
patients (Patients I, II, III, VI, VII, and VIII), and unilateral temporal
lobe spiking in the other two (Patients IV and V). Ictal recordings
showed seizures arising mainly from the left temporal lobe in ﬁveTable 1
Patient demographics and pre-operative data.
Patient Sex Age at surgery Age seizure onset Video-EEG inte
I M 27 15 Bitemporal 
II M 29 22 Bitemporal 
III M 23 11 Bitemporal 
IV F 28 0.5 Right temporal
V M 46 12 Left temporal 
VI F 45 18 Bitemporal 
VII M 36 1 Bitemporal 
VIII M 46 18 Bitemporal 
IX M 55 8 Bitemporal 
Sz, seizure; SzF, seizure frequency, CPS, complex partial seizure; GTCS, generalised tonic–
F, female.patients (Patients I, II, III, V and VI) and from the right temporal
lobe in four patients (Patients IV, VII, VIII, and IX).
The MRI was normal in three patients (Patients III, VI, and VIII).
Four patients had bilateral mesial temporal sclerosis (Patients II, V,
VII, and IX) and two had unilateral mesial temporal sclerosis
(Patients I and IV; one left, and one right). (Table 1)
Patients were included if they were not good candidates for
resection (i.e., presence of bilateral MTS, left temporal lobe
epilepsy with normal MRI) or declined to undergo resective
surgery (i.e., unilateral MTS).
The Student’s t-test was used for statistical analyses (p < 0.05
was considered signiﬁcant).
3. Results
In six patients (Patients I, II, III, V, VIII, and IX), an increase in
temporal lobe spiking was observed unilaterally at the time of
electrode insertion, as noted in a previous study13; in two patients
(Patients IV and VIII), a bilateral spiking increase was noted. In all
patients, an ipsilateral temporal lobe recruiting response (time-
locked spike-like activity) was noted during low frequency acute
stimulation. In six patients (Patients I, II, III, VI, VII, and VIII), high
frequency intra-operative hippocampal stimulation reduced or
abolished interictal spiking. We did not observe any increase in
spike frequency after high-frequency intra-operative Hip-DBS or
any after-discharges after low-frequency intra-operative
stimulation.
Hip-DBS was able to reduce seizure frequency in this series
(p < 0.05). Six patients were implanted bilaterally (Patients II, III, V,
VI, VII, VIII and IX) and two unilaterally (Patients I and IV). The side
deﬁned by the surface ictal recordings was initially activated in
those patients who received bilateral implantation; the second
side was activated only after stimulation of the ﬁrst side failed to
provide seizure frequency reduction or disappearance. The two
patients with unilateral mesial temporal sclerosis, Patients I and IV,
received unilateral implantation and experienced a 76% and an 80%
reduction in seizure frequency after Hip-DBS, respectively. In one
of these patients (Patient I), generalised tonic–clonic seizures
disappeared completely. All three patients with a normal MRI
(Patients III, VI, and VIII) were implanted bilaterally. Two of these
patients, Patients III and VIII, had unilateral activation of the
electrodes and experienced a 97% and an 80% reduction in seizure
frequency, respectively; the third patient (Patient VI) had bilateral
activation of the device and was a non-responder (12% reduction in
seizure frequency). All four patients with bilateral mesial temporal
sclerosis (Patients II, V, VII, and IX) were implanted bilaterally.
Three of these patients, Patients II, VII and IX, had unilateral
activation of the device and experienced a 66%, a 66% and a 100%
reduction in seizure frequency after Hip-DBS, respectively; onerictal Video-EEG ictal MRI Sz type SzF/month
Left temporal Left MTS CPS 3
GTCS 1
Left temporal Bilateral MTS SPS-CPS 30
Left temporal Normal CPS 180
 Right temporal Right MTS CPS 5
Left temporal Bilateral MTS SPS-CPS 8
Left temporal Normal SPS-CPS 8
GTCS 1
Right temporal Bilateral MTS CPS 3
Right temporal Normal SPS-CPS 5
Right temporal Bilateral MTS CPS 30
GTCS 1
clonic seizure; SPS, simple partial seizure; MTS, mesial temporal sclerosis; M, male;
Table 2
Seizure outcome after Hip-DBS.
Patient Sz type SzF pre/month ‘‘Honeymoon’’
(weeks)
SzF post/month sz reduction
(%)
DBS Activated side Voltage FU/months
I CPS 3 4 0.7 76 Left temporal Left 2.7 20
GTCS 1 0 100
II SPS-CPS 30 3 10 66 Bitemporal Left 1 20
III CPS 180 0 4 97 bitemporal Left 2.5 21
IV CPS 5 0 1 80 Right temporal Right 1 15
V SPS-CPS 8 0 12 50 Bitemporal Bilateral Left 2.7; right 1.5 38
VI SPS-CPS 8 0 7 12 Bitemporal Bilateral Left 2.5; right 1.5 36
GTCS 1 0 100
VII CPS 3 6 1 66 Bitemporal Right 3.5 35
VIII SPS-CPS 5 0 1 80 Bitemporal Right 2.7 36
IX CPS 30 5 0 100 Bitemporal Right 2.8 50
GTCS 1 0 100
Sz, seizure; SzF, seizure frequency; pre, preoperative; post, postoperative; FU, follow-up; CPS, complex partial seizure; GTCS, generalised tonic–clonic seizure; SPS, simple
partial seizure.
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non-responder (no reduction in seizure frequency). Overall,
seizure frequency reduction ranged from 66–100% (mean = 86.5%)
in patients with unilateral stimulation. Whenever present (three
patients; I, VII and IX), generalised tonic–clonic seizures dis-
appeared completely after Hip-DBS. Patients with bilateral
stimulation (Patients V and VI) were non-responders. (Table 2)
In four patients (Patients I, II, VII and IX), a seizure frequency
decrease greater than 50% was initially noted (honeymoon effect),
and attributed to a microlesional effect (mean duration = 4.5
weeks). These patients waited for their seizure frequency to return
to baseline before having their generators activated.
Duration and frequency of the stimuli were kept the same
during the study (300 ms; 130 Hz). Voltage ranged from 1–3.5 V
(mean = 2.2 V). Three patients (Patients I, II and V) had increased
seizure frequency while trying to increase voltage faster than usual
(at 0.5 V); an adequate titration using 0.2 V increments made it
possible to increase voltage in these patients without any adverse
events. One patient needed explantation of the device 2 years after
surgery due to infection related to trauma with direct impact to the
generator (Patient IX). There was no other morbidity or mortality.
Post-operative CT scans demonstrated an adequate positioning
of the electrodes in all patients.
4. Discussion
Although it included a relatively small number of patients, this
prospective cohort showed that Hip-DBS was safe and effective in
our patients with refractory temporal lobe epilepsy. Seven of the
nine patients were considered responders, and seizure frequency
reduction and seizure freedom rates were higher than those reported
after thalamic stimulation and previous Hip-DBS series,9–11although
we are likely comparing different patient populations. There was no
difference regarding seizure outcome after Hip-DBS among the
different aetiologies as deﬁned by MRI. Velasco et al.12 suggested that
patients with a normal MRI would respond better to Hip-DBS, but
this was not noted in this series. Hip-DBS was extremely effective in
the control of generalised tonic–clonic seizures in this patient
population.
We used electrodes developed for the treatment of Parkinson’s
disease in this series. These quadripolar electrodes span a length of
1.15 cm, meaning that we were actually stimulating the head and
anterior portions of the body of the hippocampus, and not the
whole hippocampus. A more adequate electrode would need to be
3.5 cm in length, and include more contacts (possibly 8), to be able
to more adequately cover the hippocampal formation. Additional-
ly, it is likely that some of the contacts were located within the
parahippocampus itself; this might have occurred because thehippocampus is a slightly arched structure. In patients with severe
mesial temporal sclerosis, the hippocampus is very small and hard,
and might cause deviation of the electrode into the parahippo-
campus or the lateral ventricle. We believe that improvement in
hardware conﬁguration might lead to results even better than
those reported here.
Contrary to thalamic stimulation, where seizure frequency
increase is rarely seen after a voltage increase of 0.5 V, such
increases in voltage might lead to seizure frequency worsening
during Hip-DBS. Voltage increments during Hip-DBS should not
exceed 0.2 V. Even those patients who showed seizure frequency
worsening after a 0.5 V increase were able to tolerate much higher
voltages when 0.2 V increments were used. The mean ﬁnal voltage
in the present series was lower than that in patients who
underwent thalamic stimulation.
Intra-operative low-frequency stimulation generated a recruit-
ing rhythm restricted to the stimulated temporal lobe, as we noted
in a previous study.13 This was in sharp contrast to the intra-
operative ﬁndings after thalamic stimulation, during which
widespread, bilateral recruiting rhythms were noted after unilat-
eral stimulation. We considered the recording of such localised
recruiting rhythms as a good indicator of adequate electrode
placement and hardware functioning. We tested 130 Hz high-
frequency stimulation in this series. In a previous study,12 we
showed that turning the generator off after acute high-frequency
intra-operative stimulation that abolished spiking led to the re-
appearance of spikes, which could be abolished again by re-
starting the stimulation. This was a reproducible phenomenon,
favouring a Hip-BDS effect and not a spontaneous ﬂuctuation of
spike frequency.
Half of these patients appeared to experience a microlesional
effect inducing a seizure frequency decrease immediately after
implantation, without generator activation.14 Although this effect
is also present in patients who underwent anterior thalamic
stimulation, it appears to be much more frequent in patients
receiving Hip-DBS.
Patients were unaware of the Hip-DBS. We used the same
stimulation paradigm for patients with either a normal MRI or
MTS. Although neuropsychological ﬁndings were not the aim of
this study, we observed no self-reported memory deterioration,
even in those patients who received bilateral Hip-DBS. Statistical
analysis did not show any differences related to outcome between
patients with a normal MRI or MTS, although the number of
patients is too small for an adequate analysis.
We did not see improvement in our patients who shifted from
unilateral to bilateral Hip-DBS, as was noted by Vonck et al.; the
small number of patients worldwide receiving bilateral Hip-DBS
precludes any adequate conclusion at this point. We used
A. Cukiert et al. / Seizure 23 (2014) 6–9 9continuous Hip-DBS in this series; others have used either
intermittent or cycled stimulation. Because there are no random-
ised trials comparing the different stimulation paradigms, the
optimal parameters for Hip-DBS remain unknown.
Hip-DBS might represent a useful therapeutic option in patients
with refractory temporal lobe epilepsy who were not candidates
for resective surgery or have had previous failed procedures.
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